Bioscience Animal Health PCL

Bioscience Animal Health PCL EBIT

The EBIT of Bioscience Animal Health PCL (BIS.BK) as of Oct 18, 2026 is 19.87 M THB. In the previous year, EBIT was 94.84 M THB — a change of -79.05% (lower).

EBIT

19.87 MTHB

YoY

-79.05%

Last updated:

In 2025, Bioscience Animal Health PCL's EBIT was 19.87 M THB, a -79.05% increase from the 94.84 M THB EBIT recorded in the previous year.

The Bioscience Animal Health PCL EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT
Date
EBIT
Jan 1, 2018
14.33 M THB
Jan 1, 2019
27.44 M THB
Jan 1, 2020
78.84 M THB
Jan 1, 2021
96.24 M THB
Jan 1, 2022
82.03 M THB
Jan 1, 2023
68.29 M THB
Jan 1, 2024
94.84 M THB
Jan 1, 2025
19.87 M THB
The Bioscience Animal Health PCL EBIT history
YEAREBITYoY
19.87 MTHB-79.05%
94.84 MTHB+38.88%
68.29 MTHB-16.76%
82.03 MTHB-14.76%
96.24 MTHB+22.06%
78.84 MTHB+187.33%
27.44 MTHB+91.46%
14.33 MTHB-45.98%
26.53 MTHB—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bioscience Animal Health PCL Revenue

Bioscience Animal Health PCL Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2018
352.71 M THB
14.33 M THB
6.83 M THB
Jan 1, 2019
371.82 M THB
27.44 M THB
36.57 M THB
Jan 1, 2020
1.76 B THB
78.84 M THB
54.45 M THB
Jan 1, 2021
1.97 B THB
96.24 M THB
72.40 M THB
Jan 1, 2022
2.19 B THB
82.03 M THB
55.92 M THB
Jan 1, 2023
2.41 B THB
68.29 M THB
50.71 M THB
Jan 1, 2024
2.32 B THB
94.84 M THB
65.04 M THB
Jan 1, 2025
2.25 B THB
19.87 M THB
38.47 M THB

Bioscience Animal Health PCL Margins

Bioscience Animal Health PCL stock margins

The Bioscience Animal Health PCL margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Bioscience Animal Health PCL. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Bioscience Animal Health PCL.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
24.96 %
4.06 %
1.94 %
Jan 1, 2019
27.50 %
7.38 %
9.84 %
Jan 1, 2020
18.10 %
4.48 %
3.09 %
Jan 1, 2021
17.57 %
4.87 %
3.67 %
Jan 1, 2022
14.44 %
3.74 %
2.55 %
Jan 1, 2023
13.80 %
2.83 %
2.10 %
Jan 1, 2024
14.88 %
4.08 %
2.80 %
Jan 1, 2025
15.18 %
0.88 %
1.71 %

Bioscience Animal Health PCL Stock analysis

What does Bioscience Animal Health PCL do? Bioscience Animal Health PCL, listed on the Stock Exchange of Thailand with ticker BIS.BK and ISIN THA776010003, operates in the Health Care sector. The company is headquartered in Pak Kret, Thailand, and completed its initial public offering on May 5, 2022. Bioscience Animal Health PCL is engaged in the manufacturing, importing, and distribution of medical supplies, tools, equipment, and products for livestock and pets. The company emphasizes collaboration with specialist veterinarians to select products aimed at enhancing animal health. Its product portfolio includes antibiotics, additives, BiSMiX B-Series, BiSMiX SD Series, injections, mold inhibitors, water-soluble products, and vaccines. Specific antibiotic products mentioned are Omnicide FG II 1 Lit, Green Bioxide 20Liter, Salinopharm, Cevazuril, and Porcillin. Injection products include Zuprevo, Nuflor, Ceva, and Enzaprost. The company also provides services such as comprehensive farm advisory, disease prevention and surveillance programs, serological examination and diagnosis, biosafety and hygiene management, analysis of feed raw materials, preparation of feed formulations, feed production inspection and monitoring, and management and upskilling of farm personnel. The company's website is https://bis-group.com/. Bioscience Animal Health PCL is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Bioscience Animal Health PCL's EBIT

Bioscience Animal Health PCL's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Bioscience Animal Health PCL's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Bioscience Animal Health PCL's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Bioscience Animal Health PCL’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Bioscience Animal Health PCL stock

EBIT of Bioscience Animal Health PCL is 19.87 M THB in 2025.

EBIT of Bioscience Animal Health PCL changed from 94.84 M THB to 19.87 M THB, representing a -79.05% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Bioscience Animal Health PCL since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's THB is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Bioscience Animal Health PCL historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Bioscience Animal Health PCL

All Key Metrics — Bioscience Animal Health PCL